There has been a fundamental conflict between German media companies and providers of so-called advertising blockers used on the internet. The German Federal Court of Justice has just had to address this conflict in a recent case, as we discuss in this blog.
Some companies create valuable brands with great ambition and perseverance, brands that are surrounded by an aura of luxury or have an image of absolute coolness. In this blog we look at a recent German decision concerning the Japanese luxury KANEBO brand, which follows soon after the landmark CJEU ruling in COTY.
The Advocate General's clarification of the 'Specific Mechanism' in Pfizer Ireland Pharmaceuticals v Orifarm
Advocate General Tanchev recently gave his opinion in Pfizer Ireland Pharmaceuticals v Orifarm concerning parallel imports of etanercept (a drug used for treating arthritis) from new member states into Germany. The Regional Court in Düsseldorf referred questions to the CJEU seeking guidance on the scope of the so-called 'specific mechanism' exception.